Clinical Trials

982 enrolled

Anorexia, Cachexia, Fatigue, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Weight Loss

NCT06697301 2026-05-08

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

740 enrolled

Neoplasm Metastasis

NCT06943755 2026-04-17

STELLAR-311

440 enrolled

EndocrineNET

Adenoma, Islet Cell, Neoplasm Metastasis, Neuroendocrine Tumors

NCT06947928 2026-04-17

Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell Carcinoma

118 enrolled

Neoplasm Metastasis, Skin Neoplasms, Carcinoma, Merkel Cell

NCT04787744 2026-04-08

VA STARPORT

Phase 2/3 Enrolling by invitation

464 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT06506955 2026-04-03

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

15 enrolled

Neoplasm Metastasis, Cholangiocarcinoma

NCT07509398 2026-04-03

FMT Combined With Standard First-Line Therapy in Initially Unresectable Colorectal Cancer

220 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT06581406 2026-04-02

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

280 enrolled

Uveal Melanoma, Melanoma, Neoplasm Metastasis

NCT07426094 2026-03-23

PRO-BOOST-N

1,600 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT02491632 2026-03-18

Physical Activity and Dexamethasone in Reducing Cancer-Related Fatigue in Patients With Advanced Cancer

90 enrolled 13 charts

Fatigue, Neoplasm Metastasis, Neoplasms, Recurrence

NCT03021486 2026-03-18

Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recurrent Cancer

70 enrolled 20 charts

Delirium, Neoplasm Metastasis, Recurrence

NCT05665348 2026-03-09

TRIPLET

229 enrolled

Carcinoma, Hepatocellular, Neoplasm Metastasis

NCT03927885 2026-02-19

Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer

100 enrolled

Neoplasm Metastasis

NCT07321847 2026-01-07

INJECTABL-3

717 enrolled

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT03743649 2025-12-26

Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care

110 enrolled

Delirium, Neoplasm Metastasis, Recurrence

NCT06783140 2025-12-05

PLATINUM-CAN

10 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT06100367 2025-12-02

11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours

100 enrolled

Endocrine

Adrenal Gland Neoplasms, Hyperaldosteronism, Neoplasm Metastasis

NCT01861938 2025-10-02

Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients

Phase 2/3 Withdrawn

Melanoma, Neoplasm Metastasis

NCT00922974 2025-04-29

Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis

399 enrolled 29 charts

Neoplasm Metastasis, Pain

NCT06719479 2024-12-05

A Clinical Trial to Evaluate Effect of IAE0972 Combined with Chemotherapy for R/M HNSCC or NPC(Note: It is Currently Phase II.).

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis, Recurrence

NCT03512756 2024-11-06

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

130 enrolled 13 charts

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT06337695 2024-04-02

VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer

298 enrolled

Neoplasm Metastasis, Neoplasms

NCT02288377 2023-01-18

REMINET

53 enrolled 11 charts

Neoplasm Metastasis

NCT03295565 2022-04-15

OSTRICh

100 enrolled

Neoplasm Metastasis

NCT01437514 2021-06-07

Effective Study of Preoperative Short-course Radiotherapy for the Advanced Resectable Rectal Cancer

410 enrolled

Neoplasm Metastasis, Rectal Neoplasms

NCT04890522 2021-05-18

An Open-label, Multicentre, Phase II/III RCT of PFLL Versus GP Combined With JS001 as the First-line Therapy for mNPC

622 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Neoplasm Metastasis

NCT03031444 2021-02-01

PARECEC

135 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT04710290 2021-01-25

A Cohort Study of Beta-Glucan or Beta-Glucan Compound in Metastatic Cancers

90 enrolled

Neoplasm Metastasis

NCT03909724 2020-11-13

SUNRISE-CRC

Neoplasm Metastasis, Colorectal Neoplasms

NCT00212615 2020-11-06

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

116 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT03610100 2019-10-29

ACELARATE

Phase 2/3 Suspended

328 enrolled

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT03936205 2019-05-14

Dexmedetomidine Addition to Morphine in Patients With Metastatic Cancer

18 enrolled

Neoplasm Metastasis, Pain, Intractable

NCT02186301 2019-05-07

EGFR

100 enrolled 14 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis, Neoplasms, Recurrence

NCT02711007 2018-04-23

Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy

37 enrolled

Sarcoma

Neoplasm Metastasis, Osteosarcoma

NCT03491410 2018-04-09

Breast Cancer Active Surveillance, Alternative Option, Aspirin Included

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01782274 2017-10-12

Proteome-based Immunotherapy of Brain Metastases From Breast Cancer

BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis

NCT01782287 2017-10-12

Proteome-based Immunotherapy of Lung Cancer Brain Metastases

CNSThoracic

Brain Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT00684216 2017-09-14

Second-line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer

10 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT01572727 2017-03-09

BELLE-4

416 enrolled 11 charts

Breast

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

NCT02208804 2016-11-09

SIM

25 enrolled

Digestive System Neoplasms, Liver Diseases, Neoplasm Metastasis, Colorectal Neoplasms

NCT00389155 2015-12-07

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

34 enrolled

Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasm Metastasis

NCT00561990 2015-10-15

Nimotuzumab in Adults With Pancreatic Cancer

188 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT01830231 2014-01-28

Cabazitaxel vs. Vinflunine in Metastatic or Locally Advanced Transitional Cell Carcinoma of the Urothelium (TCCU)

372 enrolled

Neoplasm Metastasis

NCT00127387 2012-06-26

Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

GenitourinarySarcomaThoracic

54 enrolled

Bone Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms

NCT00401323 2011-01-20

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

568 enrolled

Head & Neck

Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasm Recurrence, Local

NCT00561522 2010-07-21

Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection

290 enrolled

Carcinoma, Hepatocellular, Neoplasm Metastasis, Recurrence

NCT00290953 2008-12-23

SESAME

432 enrolled

Thoracic

Lung Neoplasms, Neoplasm Metastasis, Small Cell Lung Carcinoma

NCT00035334 2006-02-14

Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis

GastrointestinalGenitourinaryPlasma cell

150 enrolled

Amyloidosis, Arthritis, Rheumatoid, Gastrointestinal Diseases, Kidney Diseases, Neoplasm Metastasis, Nephrotic Syndrome, Familial Mediterranean Fever

NCT00055562 2005-06-24

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

274 enrolled